Virtual Medicinal Product (VMP) - Talimogene laherparepvec 100million plaque forming units/1ml solution for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Talimogene laherparepvec 100million plaque forming units/1ml solution for injection vials | Start Date 15-03-2016 | End Date |
| Abbreviated Name | Abbreviated Name Talimogene laherparepvec 100million plaque forming u/1ml inj | Start Date 31-03-2020 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intralesional
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intralesional
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01XL02
- BNF Codes
-
- BNF code 08010500
| Code | Start Date | End Date |
|---|---|---|
| 32453711000001109 | 15-03-2016 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Talimogene laherparepvec | Based on Ingredient Substance | 100 million plaque forming units | 1 ml |
Name
Talimogene laherparepvec
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMTalimogene laherparepvec
-
VMP(Current) Talimogene laherparepvec 100million ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |